Viatris Inc (NAS:VTRS)
$ 11.62 0 (0%) Market Cap: 13.87 Bil Enterprise Value: 30.11 Bil PE Ratio: 0 PB Ratio: 0.71 GF Score: 71/100

Viatris Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2024 / 06:30PM GMT
Release Date Price: $12.1 (+4.31%)
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst

Good morning, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be hosting a fireside chat today with Viatris. From the company, we're going to have a quick presentation from CEO, Scott Smith, and then we're going to open up to a Q&A session with the broader management team. So with that, a happy new year, everybody. And Scott, thanks for joining us.

Scott Andrew Smith
Viatris Inc. - CEO & Director

Thank you, Chris. And I'm just going to make a couple of short remarks here in a couple of quick slides. And the bulk of the presentation is going to be Q&A. I just want to show a forward-looking statement. Obviously, we're going to make some forward-looking statements during the course of this presentation.

And then -- so just good morning to everybody here and everybody who's joining via the webcast. 2013 was an outstanding year at Viatris. We integrated and simplified the company. We stabilized the base business and have seen 2 consecutive

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot